تحميل...

Treatment of heart failure in adults with thalassemia major: response in patients randomised to deferoxamine with or without deferiprone

BACKGROUND: Established heart failure in thalassaemia major has a poor prognosis and optimal management remains unclear. METHODS: A 1 year prospective study comparing deferoxamine (DFO) monotherapy or when combined with deferiprone (DFP) for patients with left ventricular ejection fraction (LVEF) &l...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Porter, John B, Wood, John, Olivieri, Nancy, Vichinsky, Elliott P, Taher, Ali, Neufeld, Ellis, Giardina, Patricia, Thompson, Alexis, Moore, Blaine, Evans, Patricia, Kim, Hae-Young, Macklin, Eric A, Trachtenberg, Felicia
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	BioMed Central 2013
الموضوعات:	Research
الوصول للمادة أونلاين:	https://ncbi.nlm.nih.gov/pmc/articles/PMC3669105/ https://ncbi.nlm.nih.gov/pubmed/23688265 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1532-429X-15-38
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

Treatment of heart failure in adults with thalassemia major: response in patients randomised to deferoxamine with or without deferiprone

مواد مشابهة